Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Krishna Institute of Medical SciencesNSE:KIMS 85 Return-on-Tangible-Equity is 9.18% as of Mar. 2026, which is 63% below its 10-year median of 24.94. GuruFocus rates NSE:KIMS with a GF Score™ of 85/100 and a GF Value™ of ₹790.22 (Fairly Valued). The stock has 7 warning signs investors should review. Among 580 Healthcare Providers & Services companies, Krishna Institute of Medical Sciences ranks better than 56.72% on this metric.
The historical rank and industry rank for Krishna Institute of Medical Sciences's Return-on-Tangible-Equity or its related term are showing as below:
NSE:KIMS'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -10.88 Med: 24.94 Max: 32.86
Current: 13.27
During the past 8 years, Krishna Institute of Medical Sciences's highest Return-on-Tangible-Equity was 32.86%. The lowest was -10.88%. And the median was 24.94%.
NSE:KIMS's Return-on-Tangible-Equity is ranked better than 56.72% of 580
companies
in the Healthcare Providers & Services industry
Industry Median: 10.085
vs NSE:KIMS: 13.27
Krishna Institute of Medical Sciences (NSE:KIMS) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Krishna Institute of Medical Sciences Return-on-Tangible-Equity Related Terms
Krishna Institute of Medical Sciences Return-on-Tangible-Equity Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Krishna Institute of Medical Sciences Return-on-Tangible-Equity Chart
NSE:KIMS vs HCA, THC, DVA: Return-on-Tangible-Equity Comparison
For the Medical Care Facilities subindustry, Krishna Institute of Medical Sciences's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Krishna Institute of Medical Sciences Return-on-Tangible-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Krishna Institute of Medical Sciences's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Krishna Institute of Medical Sciences's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 9.18% mean?
Krishna Institute of Medical Sciences (NSE:KIMS) has a Return-on-Tangible-Equity of 9.18% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Krishna Institute of Medical Sciences and its competitors. This is 63% below median its historical median of 24.94. According to the industry distribution chart, Krishna Institute of Medical Sciences ranks #251 out of 580 companies in the Healthcare Providers & Services industry, placing it in the top 43.3%.
Is Krishna Institute of Medical Sciences' Return-on-Tangible-Equity too high?
Krishna Institute of Medical Sciences' current Return-on-Tangible-Equity of 9.18% is 63% below median its 10-year median of 24.94. The Healthcare Providers & Services industry median Return-on-Tangible-Equity is 10.09. Krishna Institute of Medical Sciences' value of 9.18% is 9% below this industry median. Based on the distribution chart, Krishna Institute of Medical Sciences ranks #251 out of 580 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Krishna Institute of Medical Sciences has a GF Score™ of 85/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Krishna Institute of Medical Sciences' Return-on-Tangible-Equity compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Krishna Institute of Medical Sciences ranks #251 out of 580 companies for Return-on-Tangible-Equity. This puts Krishna Institute of Medical Sciences in the upper half of its industry. The industry median Return-on-Tangible-Equity is 10.09. Krishna Institute of Medical Sciences' value of 9.18% is 9% below this benchmark. While the company's 10-year median is 24.94 vs. the industry median of 10.09, Krishna Institute of Medical Sciences has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Healthcare Providers & Services company?
The median Return-on-Tangible-Equity among Healthcare Providers & Services companies is 10.09, based on 580 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Krishna Institute of Medical Sciences's current Return-on-Tangible-Equity of 9.18% is 9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Krishna Institute of Medical Sciences and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Equity is 10.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Krishna Institute of Medical Sciences's current Return-on-Tangible-Equity is 9.18%, which is 63% below median its own 10-year median of 24.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Krishna Institute of Medical Sciences stock overvalued right now?
Based on GuruFocus' analysis, Krishna Institute of Medical Sciences (NSE:KIMS) is currently considered Fairly Valued. The stock's GF Value™ is ₹790.22, compared to a current price of ₹802.95 — trading 1.6% above its estimated fair value. The current Return-on-Tangible-Equity is 9.18%, which is 63% below median its 10-year median of 24.94 and 9% below the Healthcare Providers & Services industry median of 10.09. Krishna Institute of Medical Sciences' overall GF Score™ is 85/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Krishna Institute of Medical Sciences (NSE:KIMS), the current Return-on-Tangible-Equity is 9.18% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Krishna Institute of Medical Sciences (NSE:KIMS) Overvalued in 2026?
Based on GuruFocus' analysis, Krishna Institute of Medical Sciences stock appears to be overvalued.
The current stock price of ₹802.95 is trading 1.6% above its estimated GF Value™ of ₹790.22.
GuruFocus considers Krishna Institute of Medical Sciences to be Fairly Valued.
Key valuation signals for NSE:KIMS:
Return-on-Tangible-Equity: 9.18% (63% below median its 10-year median of 24.94)
GF Value™: ₹790.22 vs. price of ₹802.95 (1.6% above fair value)
Industry Position: 9% below the Healthcare Providers & Services median (#251 of 580)
No single metric tells the full story. See the NSE:KIMS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Krishna Institute of Medical Sciences Business Description
Krishna Institute of Medical Sciences Ltd is a healthcare group in Secunderabad and Telangana. It offers a comprehensive range of healthcare services, including oncology, cardiac sciences, neurosciences, gastric sciences, orthopedics, renal sciences, organ transplantation, mother and child care, and many more. The firm generates key revenue from Hospital services and Pharmacy.
85GF Score
Get the complete analysis for NSE:KIMS
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:KIMS has been successfully added to your 
